Copy to clipboard 
N2 Biomedical was awarded U.S. patents protecting their proprietary Dual Action NanoCoating and their Mesoporous Surface for Enhanced Bone Integration process.
U.S. Patent No. 10,675,380 protects the Dual Action NanoCoating process, which deposits biocompatible and antibacterial properties into a single film less than 10 microns thick. The nano-engineered surface reduces bacterial colonization and biofilm formation. Biocompatible materials and engineered surface morphologies combine to enhance osseointegration.
U.S. Patent No. 10,588,999 describes the process for creating Mesoporous Surface for Enhanced Bone Integration. The proprietary coating is designed to enhance bone integration by engineering multiple levels of texture on a medical device surface, including macro, micro and meso or sub-nanoscale levels.
“This low-temperature process can be applied to a wide variety of metal, ceramic and polymer implants,” said Randall Sword, President and CEO of N2 Biomedical. “It is particularly well-suited to Polyether ether ketone (PEEK) spinal interbodies, interference screws and suture anchors. The mesoporus surface structure improves the ossointegration of PEEK implants yet maintains all material property advantages of PEEK over titanium implants which include mechanical similarity to bone, radio translucency and ease of surgical revisions.”
